Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The only GLP-1R/GIPR dual agonist with a 1:1 potency ratio
Neither compound should be understood as a proven anti-aging or general fat-loss agent, and both are prohibited in sport by the World Anti-Doping Agency (WADA)
How to Transition from Tirzepatide to Compounded Semaglutide If your provider determines that a switch to compounded semaglutide is appropriate, they may recommend the following approach: Gradual Dose Adjustment: Depending on your current dose of tirzepatide, your provider may start you at a lower compounded semaglutide dose and adjust it over time
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrm syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
In doing so, GLP-1 RAs stimulate insulin release while suppressing glucagon secretion and slowing gastric emptying, ultimately reducing appetite
US$ 25.32
US$ 28.86
US$ 24.68
US$ 21.44
US$ 25.47
